BCAX · Company research
Bicara Therapeutics Inc. Common Stock (BCAX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Bicara Therapeutics (BCAX) Stock May Look Overvalued On Book Value - Yahoo Finance Singapore | Bicara Therapeutics (BCAX) Stock May Look Overvalued On Book Value Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 10, 2026 | neutral | 0 | 0.6 |
| T. Rowe Price lists 2.8 million shares in Bicara Therapeutics (BCAX) ownership amendment. - Stock Titan | T. Rowe Price lists 2.8 million shares in Bicara Therapeutics (BCAX) ownership amendment. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| How (BCAX) Movements Inform Risk Allocation Models - Stock Traders Daily | How (BCAX) Movements Inform Risk Allocation Models Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 7, 2026 | neutral | 0 | 0.6 |
| How BCAX Corp (BCAX) Affects Rotational Strategy Timing - Stock Traders Daily | How BCAX Corp (BCAX) Affects Rotational Strategy Timing Stock Traders Daily | View source ↗ | Stock Traders Daily | Sep 27, 2026 | neutral | 0 | 0.6 |
| Bicara interim CEO sells 17,500 shares after option exercise | BCAX Insider Trading - Stock Titan | Bicara interim CEO sells 17,500 shares after option exercise | BCAX Insider Trading Stock Titan | View source ↗ | Stock Titan | Sep 10, 2026 | neutral | 0 | 0.6 |
| Trading Systems Reacting to (BCAX) Volatility - Stock Traders Daily | Trading Systems Reacting to (BCAX) Volatility Stock Traders Daily | View source ↗ | Stock Traders Daily | Aug 27, 2026 | neutral | 0 | 0.6 |
| How Bicara’s Leadership Overhaul and CEO Succession Plan Could Shape Bicara Therapeutics (BCAX) Investors - Simply Wall Street | How Bicara’s Leadership Overhaul and CEO Succession Plan Could Shape Bicara Therapeutics (BCAX) Investors Simply Wall Street | View source ↗ | Simply Wall Street | Aug 24, 2026 | neutral | 0 | 0.6 |
| Bicara Therapeutics (BCAX) Reshapes Leadership As Commercialization Hopes Meet An Undervalued View - Simply Wall Street | Bicara Therapeutics (BCAX) Reshapes Leadership As Commercialization Hopes Meet An Undervalued View Simply Wall Street | View source ↗ | Simply Wall Street | Aug 18, 2026 | neutral | 0 | 0.6 |
| BCAX Stock Price and Chart — NASDAQ:BCAX - TradingView | BCAX Stock Price and Chart — NASDAQ:BCAX TradingView | View source ↗ | TradingView | Aug 17, 2026 | neutral | 0 | 0.6 |
| Bicara Therapeutics: My Optimism Is Building Despite Recent Market Headwinds (NASDAQ:BCAX) - Seeking Alpha | Bicara Therapeutics: My Optimism Is Building Despite Recent Market Headwinds (NASDAQ:BCAX) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 12, 2026 | neutral | 0 | 0.6 |
| Bicara Therapeutics Reports $55.4 Million Q2 Net Loss and CEO Transition | BCAX Stock News - Quiver Quantitative | Bicara Therapeutics Reports $55.4 Million Q2 Net Loss and CEO Transition | BCAX Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 11, 2026 | neutral | 0 | 0.6 |
| BCAX Forecast — Price Target — Prediction for 2027 - TradingView | BCAX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| A Look At Bicara Therapeutics (BCAX) Valuation After Recent Share Price Pullback - Yahoo Finance | A Look At Bicara Therapeutics (BCAX) Valuation After Recent Share Price Pullback Yahoo Finance | View source ↗ | Yahoo Finance | May 19, 2026 | neutral | 0 | 0.6 |
| Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet - Yahoo Finance | Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet Yahoo Finance | View source ↗ | Yahoo Finance | May 15, 2026 | neutral | 0 | 0.6 |
| Insider Sale: Chief Executive Officer of $BCAX Sells 15,000 Shares - Quiver Quantitative | Insider Sale: Chief Executive Officer of $BCAX Sells 15,000 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 20, 2026 | neutral | 0 | 0.6 |
| Should I buy Bicara Therapeutics Inc. (BCAX) - Zacks Investment Research | Should I buy Bicara Therapeutics Inc. (BCAX) Zacks Investment Research | View source ↗ | Zacks Investment Research | Apr 1, 2026 | neutral | 0 | 0.6 |
| Bicara Therapeutics Inc. Common Stock (BCAX) Stock Price: Oct 2 Close $17.63 - Gotrade | Bicara Therapeutics Inc. Common Stock (BCAX) Stock Price: Oct 2 Close $17.63 Gotrade | View source ↗ | Gotrade | Jan 26, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Sep 10, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.